Comparing two drugs to make peritoneal cancer surgery possible
Treatments studied
Part of Cancer, Digestive system clinical trials.
This study tests two medicines, paricalcitol (a form of vitamin D) and pirfenidone, to see if they can shrink or change peritoneal cancer so that surgery to remove it becomes possible. You may join if you have had at least three months of chemotherapy but the cancer is still present.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 81 years old.
- You have a confirmed diagnosis of peritoneal cancer that has spread within the abdomen.
- You have had at least three months of standard chemotherapy, and the cancer has not gone away.
- You are in good enough health to carry out daily activities (ECOG performance status 0 or 1).
- Your organ function is adequate, and if you are a woman who could become pregnant, you must have a negative pregnancy test.
- You must be willing and able to follow the study procedures and give written consent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 1 trial tests a treatment that delivers heated chemotherapy directly into the abdomen (HIPEC) for certain cancers that have spread only within the abdominal lining. It aims to see how safely and effectively this approach works, especially when doctors can remove as much tumor as possible.
This Phase 2 study tests whether a modified chemotherapy given inside the abdomen soon after surgery is practical and safe. It may help people with appendix or colon cancer that has spread within the abdomen (peritoneal carcinomatosis) by targeting cancer cells after tumor removal.
This Phase 1 trial tests PIPAC, a way to deliver anti-cancer medicine directly into the abdomen using a minimally invasive procedure. It is for people with peritoneal spread from certain cancers to see whether this approach is safe and potentially helpful.
This trial checks whether having surgery to remove as much tumor as possible, followed by ongoing targeted treatment, helps people with advanced ovarian (and related) cancers live longer and/or control cancer better. It specifically uses tumor-testing results to match patients and then continues treatment after surgery.
This Phase 2 trial compares two different treatment strategies as the first chemotherapy after surgery for advanced epithelial ovarian, peritoneal, or fallopian-tube cancer. It may help doctors find a more effective or better-tolerated approach for people in your situation.
This trial tests a combination of three drugs (regorafenib, toripalimab, and albumin-bound paclitaxel) as a third-line treatment for advanced pancreatic cancer that has progressed after two prior therapies. The goal is to see if this combination can help shrink tumors or slow the cancer's growth.
Hear when a new Peritoneal (Metastatic) Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.